Noninvasive Mapping Before Surgical Ablation

NCT ID: NCT06803615

Last Updated: 2025-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-13

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the electrophysiological mechanism of atrial fibrillation by means of a beat-to-beat noninvasive 3D mapping method in patients with concomitant persistent and long-standing persistent atrial fibrillation undergoing surgical ablation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation (AF)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrocardiographic imaging

Electrocardiographic imaging is an electrophysiological mapping technique which is used to noninvasively map cardiac arrhythmias.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Noninvasive surface mapping Noninvasive mapping Beat-to-beat noninvasive 3D mapping

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* legal age (18-90a)
* life expectancy \> 2 years
* patients suffering from persistent and long standing atrial fibrillation
* scheduled for concomitant surgical ablation
* possibility to follow-up
* given informed consent

Exclusion Criteria

* vulnerable patient groups
* pregnancy
* any previous surgical ablation
* acute surgical indications
* any physical condition that leads to a life expectancy of less than two years
* any contraindication to the treatments necessary for the trial's conduction as e.g.

* known allergic reaction to contrast agent
* known allergic reaction to antiarrhythmic drugs
* claustrophobia or anxiety in small spaces
* severe renal impairment
* unmanageable hyperthyroidism
* participation in any other clinical trial that either excludes enrolment or may be a confounding factor to results
* voluntary retention
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emilio Osorio, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emilio Osorio, MD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

References

Explore related publications, articles, or registry entries linked to this study.

Osorio-Jaramillo E, Conci L, Schloglhofer T, Coti I, Strassl A, Schukro C, Zimpfer D, Ehrlich MP, Ad N. Electrocardiographic Imaging as Preoperative Tool in Persistent and Long-Standing Persistent Atrial Fibrillation: A Prospective Observational Study. Interdiscip Cardiovasc Thorac Surg. 2025 Sep 1;40(9):ivaf198. doi: 10.1093/icvts/ivaf198.

Reference Type DERIVED
PMID: 40828886 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1046/2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phase-Aligned Atrial Fibrillation Mapping
NCT06892561 ACTIVE_NOT_RECRUITING